Literature DB >> 23464957

Lamina osteotomy and replantation with miniplate fixation for thoracic myelopathy due to ossification of the ligamentum flavum.

Zhi-Hong Nie1, Fa-Jing Liu, Yong Shen, Wen-Yuan Ding, Lin-Feng Wang.   

Abstract

Lamina osteotomy and replantation with miniplate fixation is often used to treat benign intradural tumors, effectively preventing nerve entrapment and postoperative spinal deformities. However, no studies report using this technique to treat thoracic myelopathy due to ossification of the ligamentum flavum (OLF). This article reports the clinical outcome of a series of 18 cases of contiguous multilevel OLF treated by lamina osteotomy and replantation with miniplate fixation.Eighteen consecutive patients at the authors' institution were treated between 2008 and 2010 for contiguous multilevel OLF. Clinical efficacy, operative time, blood loss, sagittal alignment, and complications were investigated. Japanese Orthopaedic Association scale scores improved from 4.7±1.4 preoperatively to 7.9±1.3 three months postoperatively and 8.8±1.3 at final follow-up (P<.01), with a mean recovery rate of 67.8%±13.1%. No significant kyphotic deformity occurred postoperatively, and local kyphosis in the treated area increased by a mean of only 1.9°±1.0° at final follow-up. No patient required additional surgery due to spinal canal reobstruction and progressive spinal deformity. Cerebrospinal fluid leakage occurred in 4 patients and resolved after repair. Pulmonary infection and deep venous thrombosis occurred in 1 patient who was discharged with no complications after routine treatment.Lamina osteotomy and replantation with miniplate fixation is an effective therapeutic option for thoracic myelopathy due to contiguous multilevel OLF compression. The technique provides adequate decompression and stabilized sagittal alignment and avoids invasion of the spinal canal by scar tissue. Copyright 2013, SLACK Incorporated.

Entities:  

Mesh:

Year:  2013        PMID: 23464957     DOI: 10.3928/01477447-20130222-26

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  7 in total

Review 1.  A systematic review of complications in thoracic spine surgery for ossification of ligamentum flavum.

Authors:  Xiaofei Hou; Zhongqiang Chen; Chuiguo Sun; Guangwu Zhang; Sijun Wu; Zheng Liu
Journal:  Spinal Cord       Date:  2017-12-28       Impact factor: 2.772

2.  Transforaminal endoscopic decompression for thoracic spinal stenosis under local anesthesia.

Authors:  Zhi-Qiang Jia; Xi-Jing He; Li-Tao Zhao; San-Qiang Li
Journal:  Eur Spine J       Date:  2018-01-20       Impact factor: 3.134

3.  Benefits and Risks of Subsection Laminectomy with Pedicle Screw Fixation for Ossification of the Ligamentum Flavum of the Thoracic Spine: A Retrospective Study of 30 Patients.

Authors:  Yong Wang; Liu Yang; Tao Lei; Yong-Sheng Lin; Xiang-Bei Qi; Zhi-Hong Wang; Jun-Ming Cao
Journal:  Med Sci Monit       Date:  2019-08-23

4.  Subsection Laminectomy with Pedicle Screw Fixation to Treat Thoracic Ossification of Ligamentum Flavum: A Comparative Analysis with Lamina Osteotomy and the Replantation Technique.

Authors:  Jing-Tao Zhang; Tao Lei; Liu Yang; Yong-Sheng Lin; Zhi-Hong Wang; Jun-Ming Cao
Journal:  Ther Clin Risk Manag       Date:  2020-04-17       Impact factor: 2.423

5.  Preliminary report of modified expansive laminoplasty in the treatment of thoracic ossification of the ligamentum flavum.

Authors:  You-Di Xue; Zhao-Chuan Zhang; Chao Ma; Wei-Xiang Dai
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

6.  A systematic review of surgical procedures on thoracic myelopathy.

Authors:  Shiqi Zhu; Yu Wang; Peng Yin; Qingjun Su
Journal:  J Orthop Surg Res       Date:  2020-12-10       Impact factor: 2.359

7.  Bilateral translaminar osseous-channel assisted percutaneous full-endoscopic ligamentectomy decompression for thoracic myelopathy due to ossification of the ligamentum flavum: a technical note.

Authors:  Zhijun Xin; Weijun Kong; Qian Du; Wenbo Liao
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-11-15       Impact factor: 1.195

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.